LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
What FDA’s 2026 GLP-1 safety crackdown means for patients using compounded semaglutide or tirzepatide
FDA’s 2026 GLP-1 crackdown targets compounded or illegally marketed products, not approved brands. Here’s how patients can verify what they’re taking.
Whooping Cough Stayed High in the U.S. What Families Should Know About Vaccines, Testing, and Calling Ahead
Whooping cough stayed elevated in the U.S. in 2025. Here’s what that means for family vaccines, test timing, and why clinics want suspected cases to call first.
Raw Cheddar Recall: What Families Should Do If This E. coli Alert Is in the Fridge
A Raw Farm cheddar recall offers a practical lesson for families: match the product, size, and date, then return or discard it without tasting it.
What SAMHSA’s 2026 988 funding could change first in local communities
SAMHSA’s 2026 988 funding may show up first as faster answers, more local routing, and stronger follow-up, not instant growth in in-person crisis care.
What the CY 2026 Medicare physician fee schedule could mean for patient access, preventive care, and physician practices
Medicare’s 2026 physician payment rule may improve care coordination, telehealth, and home visits, but local staffing and practice finances still matter.
What the New CMS Prior-Authorization Reports Can and Cannot Tell Patients in 2026
Some plans now have to post 2025 prior-authorization data. Here is what patients and clinicians can learn from the new CMS reports, and what they cannot.
Minnesota’s Medicaid funding deferral: Why providers may feel the strain before patients do
Minnesota’s Medicaid funding deferral does not automatically end coverage. The closer short-term risk is provider payment strain, tighter oversight, and access friction.
FDA Is Tightening the Rules on Compounded GLP-1 Drugs. What That Could Mean for Access, Safety, and Cost
FDA’s 2026 crackdown on mass-marketed compounded GLP-1s could tighten safety oversight but also shrink cheaper options for people struggling to afford approved drugs.
Health Equity in the 2025-2030 Dietary Guidelines: Where Families May Actually Feel It
The 2025-2030 Dietary Guidelines talk a lot about “real food,” but the bigger everyday question is whether healthy choices become easier to afford, find, and fit real life. That is where the Advisory Committee’s health-equity lens may matter most.
What the new 2025-2030 Dietary Guidelines really mean for your plate: cut ultra-processed foods first, and read the protein debate carefully
The new federal dietary guidelines matter far beyond your kitchen. For most people, the clearest takeaway is to cut back on highly processed foods, sugary drinks, and refined carbs before fixating on the newer, more debated protein and dairy shifts.
What the FDA says it is changing about infant-formula recalls after the ByHeart botulism outbreak
After the ByHeart-linked infant botulism outbreak, the FDA says it is tightening recall follow-through, making formula information easier for families to find, and expanding sampling and surveillance. Here is what changed, what parents should watch for, and what is still not fully known.
ByHeart formula botulism outbreak is over, but the recall is not: what parents should know now
Federal officials say the ByHeart-linked infant botulism outbreak is over, but all ByHeart Whole Nutrition infant formula remains recalled. Here’s what parents should do now, which symptoms need urgent care, and what is still unknown.